Glaxosmithkline PLC, 10% Owner at CVRx, Inc. (CVRX), bought 564,917 shares at $0.18 ($5.0M) on 2021-07-02, disclosed to the SEC on 2021-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 14,917 | $0 | 0.0% |
| 2 | $0.18 | 275,000 | $50K | 1.0% |
| 3 | $18.00 | 275,000 | $5.0M | 99.0% |
| Total | $8.85 avg | 564,917 | $5.0M | 100% |
| Filing → |
| DBTX | BUY | 2021-02-19 | $2.7M | — | Filing → |
| BCYC | SELL | 2020-09-18 | $151K | — | Filing → |
| GNCA | BUY | 2020-07-30 | $2.8M | — | Filing → |